Cobb Stuart bought NGNE
March 13, 2024 · Form 4 insider transaction
Cobb Stuart bought 34,450 shares of Neurogene Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
34,450
Price
$0.00
Total value
N/A
InsiderCobb Stuart
Role—
CompanyNeurogene Inc. (NGNE)
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateMarch 13, 2024
Filing dateMarch 14, 2024
Shares owned after34,450
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option vests as to 1/4 of the total number of shares on March 13, 2025, and then 1/48 of the total number of shares will vest monthly thereafter, subject to the Reporting Person's continued provision of service to the Issuer on each vesting date.